 | |  |
Codon Devices Named to Red Herring 100
CAMBRIDGE, Mass., May 2 /PRNewswire/ -- Codon Devices, Inc., the Constructive Biology Company(TM), today announced that it is a recipient of the Red Herring 100, an award given to the top 100 private technology companies in North America. Each year Red Herring honors promising early stage companies that will lead the next wave of disruption and cutting-edge innovation. Codon Devices has been recognized this year for its potential to fundamentally transform biotechnology research and development in the pharmaceutical, agriculture and renewable energy industries.
"We are honored to be recognized by Red Herring for our tremendous progress in industrializing synthetic biology with our revolutionary BioFAB(TM) technology platform," said John P. Danner, President and Chief Executive Officer of Codon Devices, "Every day we are delivering products to our rapidly expanding customer base and making our bold vision of Constructive Biology(TM) more and more of a reality. From engineered genetic constructs and highly-diverse libraries to designer proteins and enzymes, Codon Devices is truly accelerating the pace of biotechnology research and development."
"Having received more than 800 submissions, it is clear that we are witnessing a new outburst of creativity," stated Joel Dreyfuss, Editor-in- Chief of Red Herring. "With venture capital flowing again, it's exciting to see technology innovators and business investors collaborate to create disruptive technologies. The Red Herring 100 North America companies are impressive up-and-comers and definitely the ones to watch."
Red Herring's annual lists of top private companies are an important part of the company's tradition of identifying new and innovative technology companies and entrepreneurs. Companies like Google, eBay and Skype were spotted in their early days by Red Herring editors and touted as leaders that would change the way we live and work. Red Herring's editorial staff rigorously evaluated more than 800 private companies through a careful analysis of financial data and subjective criteria, including quality of management, execution of strategy, and dedication to research and development.
Codon Devices, based in Cambridge, MA, is a privately-held biotechnology company focused on enabling commercial applications of synthetic biology. Codon Devices' proprietary synthesis and design technologies improve the productivity of its industrial, pharmaceutical and academic customers in a paradigm shift to what the Company calls Constructive Biology(TM). The Company's focus is on developing and delivering high-value products and design services in a variety of application areas, including engineered gene libraries, engineered cells that produce novel pharmaceuticals, improved vaccines, agricultural products, and biorefineries for the production of industrial chemicals and energy. Codon Devices' BioFAB(TM) platform uses sophisticated informatics, robotics and sequencing technologies to accurately synthesize genetic codes orders of magnitude more rapidly and cost-effectively than other currently available technology.
Founded in 2004 within Flagship Ventures, Codon Devices commenced laboratory operations in March 2005. The Company raised $33M in two venture rounds. Investors include Alloy Ventures, Flagship Ventures, Khosla Ventures, Kleiner Perkins Caufield and Byers and Highland Capital Partners. Codon Devices' scientific founders include George Church, Harvard Medical School; Drew Endy, Massachusetts Institute of Technology; Joseph Jacobson, Massachusetts Institute of Technology Media Lab; Jay Keasling, University of California, Berkeley; and Brian Baynes, Codon Devices, Inc. More information about Codon Devices is available at http://www.codondevices.com.
Red Herring is a global media company which unites the world's best high technology innovators, venture investors and business decision makers in a variety of forums: a leading innovation magazine, an online daily technology news service, technology newsletters, and major events for technology leaders around the globe. Red Herring provides an insider's access to the global innovation economy, featuring unparalleled insights on the emerging technologies driving the economy. More information about Red Herring is available on the Internet at http://www.redherring.com.
| | |
